Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital

Washington D.C., District of Columbia 20016

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now